Instrumentvägen 19
Hägersten 126 53
Sweden
46 8 56 21 58 50
https://devyser.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 102
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Fredrik Alpsten | Chief Exec. Officer | 4,16M | S.O. | 1966 |
Mr. Ulf Klangby | Founder & Deputy CEO | S.O. | S.O. | 1969 |
Ms. Sabina Berlin | Chief Financial Officer | S.O. | S.O. | 1983 |
Mr. Goran Rydin | Chief Operating Officer | S.O. | S.O. | 1969 |
Ms. Camilla Wiberg | Chief Human Resource Officer | S.O. | S.O. | 1979 |
Mr. Theis Kipling | Chief Commercial Officer | S.O. | S.O. | 1982 |
Mr. John Murad | VP & GM of Devyser US | S.O. | S.O. | S.O. |
Devyser Diagnostics AB (publ) provides diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation, thalassemia, breast and ovarian cancer, non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company was incorporated in 2004 and is based in Hägersten, Sweden.
L’ISS Governance QualityScore de Devyser Diagnostics AB (publ) en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..